Feasibility Study of Particulate Extracellular Matrix (P-ECM) and Left Ventricular Assist Device (HVAD) Therapy in Chronic Ischemic Heart Failure Bovine Model

ASAIO Journal

Volumn 61, Issue 2, 2015, Pages 161-169

  Soucy, Kevin G ^a,b,c   Smith, Erin F ^b   Monreal, Gretel ^a,c   Rokosh, Gregg ^a   Keller, Brad B ^a,c   Yuan, Fangping ^a,c   Matheny, Robert G ^d   Fallon, Anna M ^d   Lewis, Beecher C ^d   Sherwood, Leslie C ^c   Sobieski, Michael A ^a,c   Giridharan, Guruprasad A ^b,c   Koenig, Steven C ^a,b,c   Slaughter, Mark S ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b University of Louisville   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d NONE   (United States)

Author keywords

extracellular matrix; heart failure; left ventricular assist device

Indexed keywords

BLOOD PRESSURE; CARDIOLOGY; CELL PROLIFERATION; CELLS; CYTOLOGY; ECHOCARDIOGRAPHY; EMULSIFICATION; FIBER OPTIC SENSORS; HEART; HEMODYNAMICS; MAMMALS;

CARDIAC FUNCTIONS; EJECTION FRACTION; EXTRACELLULAR MATRICES; FEASIBILITY STUDIES; HEART FAILURE; LEFT VENTRICULAR; LEFT VENTRICULAR ASSIST DEVICE (LVAD); MYOCARDIAL RECOVERY;

LEFT VENTRICULAR ASSIST DEVICES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; EXPERIMENTAL CATTLE; FEASIBILITY STUDY; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HISTOLOGY; LEFT VENTRICULAR ASSIST DEVICE; LUNG EDEMA; MALE; MEAN ARTERIAL PRESSURE; MYOCARDITIS; NONHUMAN; PARTICLE SIZE; PARTICULATE EXTRACELLULAR MATRIX; PERICARDITIS; PLEURISY; PRIORITY JOURNAL; PULSE PRESSURE; TISSUE SCAFFOLD; TREATMENT DURATION; WEIGHT GAIN; ANIMAL; BIOLOGICAL THERAPY; BLOOD FLOW; BOVINE; CARDIAC MUSCLE; DISEASE MODEL; EMULSION; EXTRACELLULAR MATRIX; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; INJECTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; PROCEDURES;

EMULSION;

ANIMALS; BIOLOGICAL THERAPY; CATTLE; DISEASE MODELS, ANIMAL; EMULSIONS; EXTRACELLULAR MATRIX; FEASIBILITY STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; INJECTIONS; MYOCARDIUM; PARTICLE SIZE; REGIONAL BLOOD FLOW; SWINE; TISSUE SCAFFOLDS; VENTRICULAR FUNCTION, LEFT;

EID: 84937642888     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000178     Document Type: Article

References (37)

1. Heidenreich PA, Albert NM, Allen LA, American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association. Circ Heart Fail 2013 6 606 619
2. Drakos SG, Kfoury AG, Selzman CH, Left ventricular assist device unloading effects on myocardial structure and function: Current status of the field and call for action. Curr Opin Cardiol 2011 26 245 255
3. Chachques JC, Trainini JC, Lago N, Cortes-Morichetti M, Schussler O, Carpentier A, Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): Clinical feasibility study. Ann Thorac Surg 2008 85 901 908
4. Loughran JH, Chugh AR, Ismail I, Bolli R, Stem cell therapy: Promising treatment in heart failure? Curr Heart Fail Rep 2013 10 73 80
5. Singelyn JM, DeQuach JA, Seif-Naraghi SB, Littlefield RB, Schup-Magoffin PJ, Christman KL, Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 2009 30 5409 5416
6. Venugopal JR, Prabhakaran MP, Mukherjee S, Ravichandran R, Dan K, Ramakrishna S, Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface 2012 9 1 19
7. Bartoli CR, Sherwood LC, Giridharan GA, Bovine model of chronic ischemic cardiomyopathy: Implications for ventricular assist device research. Artif Organs 2013 37 E202 E214
8. Zhao ZQ, Puskas JD, Xu D, Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. J Am Coll Cardiol 2010 55 1250 1261
9. Slaughter MS, Soucy KG, Matheny RG, Development of an extracellular matrix (ecm) delivery system for effective intramyocardial injection in ischemic tissue. ASAIO J 2014 60 730 736
10. Slaughter MS, Silver MA, Farrar DJ, Tatooles AJ, Pappas PS, A new method of monitoring recovery and weaning the Thoratec left ventricular assist device. Ann Thorac Surg 2001 71 215 218
11. Sherwood LC, Sobieski MA, Koenig SC, Giridharan GA, Slaughter MS, Benefits of aggressive medical management in a bovine model of chronic ischemic heart failure. ASAIO J 2013 59 221 229
12. Schroeder MJ, Perreault B, Ewert DL, Koenig SC, HEART: An automated beat-to-beat cardiovascular analysis package using Matlab. Comput Biol Med 2004 34 371 388
13. Nativi JN, Drakos SG, Kucheryavaya AY, Changing outcomes in patients bridged to heart transplantation with continuous-versus pulsatile-flow ventricular assist devices: An analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2011 30 854 861
14. Slaughter MS, Meyer AL, Birks EJ, Destination therapy with left ventricular assist devices: Patient selection and outcomes. Curr Opin Cardiol 2011 26 232 236
15. Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS, Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail 2012 5 10 16
16. Adzic A, Patel SR, Maybaum S, Impact of adverse events on ventricular assist device outcomes. Curr Heart Fail Rep 2013 10 89 100
17. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L, Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008 86 1227 1234; discussion 1234
18. Birks EJ, Tansley PD, Hardy J, Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006 355 1873 1884
19. Leor J, Tuvia S, Guetta V, Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 2009 54 1014 1023
20. Robinson KA, Li J, Mathison M, Extracellular matrix scaffold for cardiac repair. Circulation 2005 112 9 suppl I135 I143
21. Kochupura PV, Azeloglu EU, Kelly DJ, Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 2005 112 9 suppl I144 I149
22. Landa N, Miller L, Feinberg MS, Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008 117 1388 1396
23. Tan MY, Zhi W, Wei RQ, Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 2009 30 3234 3240
24. Okada M, Payne TR, Oshima H, Momoi N, Tobita K, Huard J, Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 2010 31 7678 7683
25. Kim JH, Jung Y, Kim SH, The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials 2011 32 6080 6088
26. Badylak SF, Kochupura PV, Cohen IS, The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 2006 15 suppl 1 S29 S40
27. Menasché P, Hagège AA, Vilquin JT, Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003 41 1078 1083
28. Duckers HJ, Houtgraaf J, Hehrlein C, Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: The SEISMIC trial. EuroIntervention 2011 6 805 812
29. Meyer GP, Wollert KC, Lotz J, Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006 113 1287 1294
30. Wollert KC, Meyer GP, Lotz J, Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004 364 141 148
31. Schächinger V, Erbs S, Elsässer A, REPAIR-AMI Investigators Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006 355 1210 1221
32. Hare JM, Fishman JE, Gerstenblith G, Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. JAMA 2012 308 2369 2379
33. Chugh AR, Beache GM, Loughran JH, Administration of cardiac stem cells in patients with ischemic cardiomyopathy: The SCIPIO trial: Surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012 126 11 suppl 1 S54 S64
34. Makkar RR, Smith RR, Cheng K, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet 2012 379 895 904
35. Toeg HD, Tiwari-Pandey R, Seymour R, Injectable small intestine submucosal extracellular matrix in an acute myocardial infarction model. Ann Thorac Surg 2013 96 1686 1694; discussion 1694
36. Zheng Y, Sampaio LC, Li K, Safety and feasibility of mapping and stem cell delivery in the presence of an implanted left ventricular assist device: A preclinical investigation in sheep. Tex Heart Inst J 2013 40 229 234
37. Buckberg GD, Luck JC, Payne DB, Hoffman JI, Archie JP, Fixler DE, Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol 1971 31 598 604